The disposition of five therapeutically important antimicrobial agents in llamas

被引:45
作者
Christensen, JM [1 ]
Smith, BB [1 ]
Murdane, SB [1 ]
Hollingshead, N [1 ]
机构
[1] OREGON STATE UNIV, COLL VET MED, CORVALLIS, OR 97331 USA
关键词
D O I
10.1111/j.1365-2885.1996.tb00079.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The disposition of five therapeutic antimicrobial agents was studied in llamas (Lama glama) following intravenous bolus administration, Six llamas were each given ampicillin, tobramycin, trimethoprim, sulfamethoxazole, enrofloxacin and ceftiofur at a dose of 12 mg/kg, 1 mg/kg, 3 mg/kg, 15 mg/kg, 5 mg/kg, and 2.2 mg/kg of body weight, respectively, with a wash out period of at least 3 days between treatments, Plasma concentrations of these antimicrobial agents over 12 h following i.v. bolus dosing were determined by reverse phase HPLC. Disposition of the five antimicrobial agents was described by a two compartment open model with elimination from the central compartment, and also by non-compartmental methods, From compartmental analysis, the elimination rate constant, half-life, and apparent volume of distribution in the central compartment were determined. Statistical moment theory was used to determine noncompartmental pharmacokinetic parameters of mean residence time, clearance, and volume of distribution at steady state, Based on the disposition parameters determined, and stated assumptions of likely effective minimum inhibitory concentrations (MIC) a dose and dosing interval for each of five antimicrobial agents were suggested as 6 mg/kg every 12 h for ampicillin: 4 mg/kg once a day or 0.75 mg/kg every 8 h for tobramycin; 3.0 mg/kg/15 mg/kg every 12 h for trimethoprim/sulfamethoxazole: 5 mg/kg every 12 h for enrofloxacin; and 2.2 mg/kg every 12 h for ceftiofur sodium for llamas, Steady-state peak and trough plasma concentrations were also predicted for the drugs in this study for llamas.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 53 条
[1]  
ADRIAN D, 1989, J PHARMACOKINETICS B, V17, P131
[2]   PHARMACOKINETICS OF TOBRAMYCIN IN THE CAMEL [J].
AHADI, AA ;
WASFI, IA ;
GADIR, FA ;
AMIRI, MH ;
BASHIR, AK ;
BAGGOT, JD .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1994, 17 (01) :48-51
[3]  
[Anonymous], CLIN PHARMACOKINETIC
[4]  
Baggot J D, 1977, PRINCIPLES DRUG DISP, P144
[5]   CLINICAL PHARMACOKINETICS IN VETERINARY-MEDICINE [J].
BAGGOT, JD .
CLINICAL PHARMACOKINETICS, 1992, 22 (04) :254-273
[6]  
BROOME RL, 1991, AM J VET RES, V52, P1835
[7]   COMPARATIVE PHARMACOKINETICS OF AMINOGLYCOSIDE ANTIBIOTICS [J].
BROWN, SA ;
RIVIERE, JE .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1991, 14 (01) :1-35
[8]  
BROWSER PR, 1992, J VET PHARMACOL THER, V15, P62
[9]  
BUSHBY SRM, 1969, POSTGRAD MED J, VS, P10
[10]  
CARLI S, 1993, RES VET SCI, V54, P184, DOI 10.1016/0034-5288(93)90054-J